Mankind Pharma shareholding pattern
MANKIND
2093.9
0.00 (0.00%)Last updated on 1 Feb, 2026 | 15:55 IST
BUYSELL
The current prices are delayed, login to your account for live prices
Login Summary
For Year 2025-26, Mankind Pharma reports the following shareholding: Total Promoters at 72.66%, Mutual Fund at 9.3%, Insurance at 1.12%, Foreign Institutional Investors at 11.34%, Domestic Institutional Investors at 2.79%, and Retail at 2.79%. This breakdown provides a quick snapshot of ownership distribution for Mankind Pharma in 2025-26.
Mankind Pharma FAQs
As of 02-2026, the promoter shareholding in Mankind Pharma stands at 72.66% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.
The FII and DII shareholding of Mankind Pharma is 11.34% and 2.79% respectively.
The retail shareholding of the Mankind Pharma is 2.79%.
Changes in shareholding patterns of Mankind Pharma can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.
Shareholding patterns of Mankind Pharma are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.
The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.
